Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Feasibility of Individualized Therapy for Recurrent Glioblastoma
Phase 1
Active, not recruiting
- Conditions
- Recurrent Glioblastoma
- Interventions
- Drug: Individualized therapy
- First Posted Date
- 2018-09-21
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Jennifer Clarke
- Target Recruit Count
- 30
- Registration Number
- NCT03681028
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
News
No news found